Candel Therapeutics Inc. (CADL)
NASDAQ · Healthcare
Candel Therapeutics Inc. Net Income 2020–2022
Candel Therapeutics Inc. annual/quarterly net income history and growth rate from 2020 to 2022. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Candel Therapeutics Inc. net income for the quarter ending September 30, 2022 was -8.7 M, a 46.24% decrease year-over-year.
- Candel Therapeutics Inc. net income for the twelve months ending September 30, 2022 was -29.9 M, a 10.69% increase year-over-year.
- Candel Therapeutics Inc. annual net income for 2022 was -18.8 M, a 47.97% decrease from 2021.
- Candel Therapeutics Inc. annual net income for 2021 was -36.1 M, a 104.32% increase from 2020.
- Candel Therapeutics Inc. annual net income for 2020 was -17.7 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Candel Therapeutics Inc. Net Income — FAQ
Candel Therapeutics Inc. (CADL) net income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Candel Therapeutics Inc.'s net income?
Candel Therapeutics Inc. (CADL) reported net income of -$19M for fiscal 2022.
Where can I see CADL's net income history?
The chart and table above show Candel Therapeutics Inc.'s net income by year and by quarter, including the growth rate.